320 related articles for article (PubMed ID: 31771948)
1. Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes.
Uchida Y; Goto R; Takeuchi H; Łuczak M; Usui T; Tachikawa M; Terasaki T
Drug Metab Dispos; 2020 Feb; 48(2):135-145. PubMed ID: 31771948
[TBL] [Abstract][Full Text] [Related]
2. A human blood-arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance.
Uchida Y; Takeuchi H; Goto R; Braun C; Fuchs H; Ishiguro N; Takao M; Tano M; Terasaki T
J Neurochem; 2022 Apr; 161(2):187-208. PubMed ID: 35226354
[TBL] [Abstract][Full Text] [Related]
3. Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.
Zhang Z; Tachikawa M; Uchida Y; Terasaki T
Mol Pharm; 2018 Mar; 15(3):911-922. PubMed ID: 29436232
[TBL] [Abstract][Full Text] [Related]
4. Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs.
Takeuchi H; Suzuki M; Goto R; Tezuka K; Fuchs H; Ishiguro N; Terasaki T; Braun C; Uchida Y
Pharm Res; 2022 Jul; 39(7):1393-1413. PubMed ID: 35488144
[TBL] [Abstract][Full Text] [Related]
5. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen.
Uchida Y; Zhang Z; Tachikawa M; Terasaki T
J Neurochem; 2015 Sep; 134(6):1104-15. PubMed ID: 25951748
[TBL] [Abstract][Full Text] [Related]
6. Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.
Yaguchi Y; Tachikawa M; Zhang Z; Terasaki T
Mol Pharm; 2019 May; 16(5):2021-2027. PubMed ID: 30977661
[TBL] [Abstract][Full Text] [Related]
7. Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.
Zhang Z; Uchida Y; Hirano S; Ando D; Kubo Y; Auriola S; Akanuma SI; Hosoya KI; Urtti A; Terasaki T; Tachikawa M
Mol Pharm; 2017 Nov; 14(11):3729-3738. PubMed ID: 28954515
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
9. Mirogabalin, a novel α
Yamamura N; Mikkaichi T; Itokawa KI; Hoshi M; Damme K; Geigner S; Baumhauer C
Xenobiotica; 2022; 52(9-11):997-1009. PubMed ID: 36170033
[TBL] [Abstract][Full Text] [Related]
10. Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics.
Prasad B; Johnson K; Billington S; Lee C; Chung GW; Brown CD; Kelly EJ; Himmelfarb J; Unadkat JD
Drug Metab Dispos; 2016 Dec; 44(12):1920-1924. PubMed ID: 27621205
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats.
Choudhuri S; Cherrington NJ; Li N; Klaassen CD
Drug Metab Dispos; 2003 Nov; 31(11):1337-45. PubMed ID: 14570765
[TBL] [Abstract][Full Text] [Related]
12. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
[TBL] [Abstract][Full Text] [Related]
13. Live Tissue Imaging Reveals Distinct Transcellular Pathways for Organic Cations and Anions at the Blood-Cerebrospinal Fluid Barrier.
Hu T; Zha W; Sun A; Wang J
Mol Pharmacol; 2022 May; 101(5):334-342. PubMed ID: 35193935
[TBL] [Abstract][Full Text] [Related]
14. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
[TBL] [Abstract][Full Text] [Related]
15. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
[TBL] [Abstract][Full Text] [Related]
16. Interactions of bilastine, a new oral H₁ antihistamine, with human transporter systems.
Lucero ML; Gonzalo A; Ganza A; Leal N; Soengas I; Ioja E; Gedey S; Jahic M; Bednarczyk D
Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():8-17. PubMed ID: 22616811
[TBL] [Abstract][Full Text] [Related]
17. Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.
Braun C; Sakamoto A; Fuchs H; Ishiguro N; Suzuki S; Cui Y; Klinder K; Watanabe M; Terasaki T; Sauer A
Mol Pharm; 2017 Oct; 14(10):3436-3447. PubMed ID: 28880093
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics.
Kubo Y; Ohtsuki S; Uchida Y; Terasaki T
J Pharm Sci; 2015 Sep; 104(9):3060-8. PubMed ID: 25703048
[TBL] [Abstract][Full Text] [Related]
19. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
[TBL] [Abstract][Full Text] [Related]
20. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]